According to a Securities and Exchange Commission (SEC) filing released Friday, Scalar Gauge Management sold its entire holding of 524,244 shares in Clearwater Analytics Holdings during the third ...

Business students at Northwestern aren’t using AI to shortcut their way through assignments. It’s helping them problem-solve real strategic challenges.

Clearwater Analytics Holdings, Inc. (NYSE:CWAN) is one of the Stocks to Buy with Exponential Growth Heading into 2026.

Organizations can deliver and scale exceptional customer experiences with AI, but automation only delivers full value when it's intelligently orchestrated.

Abstract: With the rapid advancement of Artificial Intelligence (AI) technologies, their applications are expanding across increasingly diverse domains. As critical infrastructure supporting AI ...

The “placebo-adjusted” weight loss achieved by Metsera’s drug at 28 weeks of treatment is roughly equal to the 13% achieved by Zebpound at the same stage in a Phase 3 study called Surmount-1, Risinger ...

Data transmitted via satellite may not be as secure as previously thought. A new study published on Monday found that communications from cellphone carriers, retailers, banks, and even militaries are ...

Satellites beam data down to the Earth all around us, all the time. So you might expect that those space-based radio communications would be encrypted to prevent any snoop with a satellite dish from ...

A wave of artificial intelligence infrastructure is sparking a massive U.S. power boom, with Goldman Sachs projecting electricity demand growth not seen since the 1990s — and it’s opening the door to ...

Bitcoin price enters euphoria phase – on-chain frameworks like cycle master forecast $180k peak, signaling bull cycle top with $260k overvalued zone in sight. The bitcoin price has now entered the ...

Researchers at Nashville's Meharry Medical College recently launched a groundbreaking initiative with global implications for health equity and scientific advancement. The GREAT Health Study aims to ...

During a live event, Martin A. Martino, MD, analyzed overall survival outcomes from the PAOLA-1, SOLO-1, and PRIMA trials. Preventing relapse of advanced ovarian cancer with PARP inhibitors is now an ...